Business ❯ Corporate Governance ❯ Investor Relations ❯ Public Companies

Securities Fraud

Corcept Investors Face Today’s Lead‑Plaintiff Deadline in Securities Case Over Relacorilant Disclosures

The case turns on whether Corcept downplayed FDA doubts about relacorilant's evidence.

Mereo Investors Face Lead‑Plaintiff Deadline in Securities Suit Over Setrusumab Trials

Varonis Investors Urged to Act as March 9 Lead-Plaintiff Deadline Nears in Securities Class Action

Varonis Investors Face March 9 Lead Plaintiff Deadline in Securities Class Action

DeFi Technologies Investors Face Jan. 30 Lead‑Plaintiff Deadline in Federal Securities Case

Inspire Medical Investors Face Jan. 5 Lead-Plaintiff Deadline in Suit Over Inspire V Rollout